News & Press Releases
Filter by:
Mintz advised Elicio Therapeutics in its $15 Million registered direct offering of common stock.
Mintz Advises Quaise Energy on $134M Series B Financing to Advance World’s First Superhot Geothermal Power Plant
July 08, 2026
Mintz advised Quaise Energy, a leading developer of utility-scale superhot geothermal energy, in the initial close of its $134 million Series B financing. The proceeds will support construction of the world's first commercial superhot geothermal power plant in Central Oregon, as well as the continued development and commercialization of Quaise's proprietary millimeter wave drilling technology.
Mintz Advises Bollé Brands on the Sale of Its SPY+ and Serengeti Eyewear Brands to Safilo Group
July 08, 2026
Mintz advised Bollé Brands, an Alvarez & Marsal Capital portfolio company, on the sale of its SPY+ and Serengeti eyewear brands to Safilo Group, a global player in the eyewear industry.
Mintz Advises on uniQure’s $259 Million Public Offering
June 25, 2026
Mintz advised the underwriters in connection with uniQure’s $259 million public offering of ordinary shares.
Mintz advised the underwriters in connection with MoonLake Immunotherapeutics’ $200 million public offering of Class A ordinary shares.
Mintz served as health regulatory counsel to LucyRx, a technology-enabled pharmacy benefit manager (PBM), in its strategic combination with Abarca Health, creating a modern, independent PBM designed to serve commercial and government clients at scale.

